Sidoti analyst James Sidoti downgraded Staar Surgical (STAA) to Neutral from Buy with a $28 price target after Alcon (ALC) announced a definitive agreement to acquire Staar for $28 per share in cash.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: